Janice Jhang ([email protected]), Harvard University, Cambridge, Massachusetts. Troyen A. Brennan, Harvard University. Biosimilars present a key opportunity to contain the growing cost of ...
Medical practices, which are simultaneously managing a high demand for care and a workforce shortage, do not wish to fight ...
New data indicate that when payment models reward clinicians for supporting patients to take an active role in their care, ...
With policy makers focusing on the role of drug manufacturers, almost no attention has been paid to the way in which ...
The momentum around global budget models, as seen in the AHEAD program and New York State’s 1115 waiver, represents a ...
Nothing about pregnancy diminishes an individual’s decision-making capacity or obviates their right to make decisions related ...
The recent election results will usher in sweeping changes for major federal health care policies, programs, and the courts.
A recent rulemaking regarding patient care decision support tools is an important step forward in ensuring safety and equity ...
Ultimately, while employers search for ways to lower health plan spending on prescription drugs, they should consider the ...
Adding pharmacists to primary care practices increases the primary care workforce because pharmacists can provide many ...
The current US Supreme Court has no fundamental understanding of a range of medical, engineering, technological, or ...
Policy makers serve an important role in overseeing private equity’s ownership of clinics and hospitals. State-based policies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback